The usefulness of three-dimensional cell culture in induction of cancer stem cells from esophageal squamous cell carcinoma cell lines

Biochemical and Biophysical Research Communications

Volumn 434, Issue 4, 2013, Pages 773-778

  Fujiwara, Daisuke ^a   Kato, Kazunori ^b,c   Nohara, Shigeo ^a   Iwanuma, Yoshimi ^a   Kajiyama, Yoshiaki ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOYO UNIVERSITY   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

3 D cell culture; Aldehyde dehydrogenase; Cancer stem cell; Esophageal cancer; Spheroid

Indexed keywords

ALDEHYDE DEHYDROGENASE; BREAST CANCER RESISTANCE PROTEIN; CARBONATE DEHYDRATASE IX; CD133 ANTIGEN; CISPLATIN; DOXORUBICIN; EPITHELIAL CELL ADHESION MOLECULE; HERMES ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL STRUCTURE; ENZYME ACTIVITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THREE DIMENSIONAL IMAGING;

ALDEHYDE DEHYDROGENASE; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; ANTINEOPLASTIC AGENTS; CARBONIC ANHYDRASES; CARCINOMA, SQUAMOUS CELL; CELL CULTURE TECHNIQUES; CELL HYPOXIA; CELL LINE, TUMOR; CISPLATIN; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; NEOPLASTIC STEM CELLS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; SOXB1 TRANSCRIPTION FACTORS; SPHEROIDS, CELLULAR; TUMOR MARKERS, BIOLOGICAL;

EID: 84878168647     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.04.008     Document Type: Article

References (35)

1. Kamangar F., Dores G.M., Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol. 2006, 24:2137-2150.
2. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics 2002. CA Cancer J. Clin. 2005, 55:74-108.
3. Frank N.Y., Schatton T., Frank M.H. The therapeutic promise of the cancer stem cell concept. J. Clin. Invest. 2010, 120:41-50.
4. Chen J., Li Y., Yu T.S., McKay R.M., Burns D.K., Kernie S.G., Parada L.F. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012, 488:522-527.
5. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
6. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
7. Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamineson C.H., Jones D.L., Weissman J., Wahl G.M. Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 2006, 66:9339-9344.
8. Takeda H., Fujimori Y., Kai S., Ogawa H., Nakano T. CD318/CUB-domain-containing protein 1 expression on cord blood hematopoietic progenitors. Exp. Ther. Med. 2010, 1:497-501.
9. Herrmann I., Baeuerle P.A., Friedrich M., Murr A., Filusch S., Rüttinger D., Majodub M.W., Sharma S., Kufer P., Raum T., Münz M. Highly efficient elimination of colorectal tumor-initiating cells by an EpCAM/CD3-bispecific antibody engaging human T cells. PLoS ONE 2010, 5:e13474.
10. Zhao J.S., Li W.J., Ge D., Zhang P.J., Li J.J., Lu C.L., Ji X.D., Guan D.X., Gao H., Xu L.Y., Li E.M., Soukiasian H., Koeffler H.P., Wang X.F., Xie D. Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44. PLoS ONE 2011, 6:e21419.
11. Soeda A., Park M., Lee D., Mintz A., Androutsellis-Theotokis A., McKay R.D., Engh J., Iwama T., Kunisada T., Kassam A.B., Pollack I.F., Park D.M. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α. Oncogene 2009, 28:3949-3959.
12. Hang D., Dong H.C., Ning T., Dong B., Hou D.L., Xu W.G. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma. Dis. Esophagus 2012, 25:638-644.
13. Deng S., Yang X., Lassus H., Liang S., Kaur S., Ye Q., Li C., Wang L.P., Roby K.F., Orsulic S., Connolly D.C., Zhang Y., Montone K., Bützow R., Coukos G., Zhang L. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS ONE 2010, 5:e10277.
14. Burger P.E., Gupta R., Xiong X., Ontiveros C.S., Salm S.N., Moscatelli D., Wilson E.L. High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells. Stem Cells 2009, 27:2220-2228.
15. Zou B., Sun S., Qi X., Ji P. Aldehyde dehydrogenase activity is a cancer stem cell maker of tongue squamous cell carcinoma. Mol. Med. Rep. 2012, 5(5):1116-1120.
16. Ginestier C., Hur M.H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., Jacquemier J., Viens P., Kleer C.G., Liu S., Schott A., Hayes D., Birnbaum D., Wicha M.S., Dontu G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1:555-567.
17. Sullivan J.P., Spinola M., Dodge M., Raso M.G., Behrens C., Gao B., Schuster K., Shao C., Larsen J.E., Sullivan L.A., Honorio S., Xie Y., Scaglioni P.P., DiMaio J.M., Gazdar A.F., Shay J.W., Wistuba I.I., Minna J.D. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res. 2010, 70:9937-9948.
18. Storms R.W., Trujillo A.P., Springer J.B., Shah L., Colvin O.M., Ludeman S.M., Smith C. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc. Natl. Acad. Sci. USA 1999, 96:9118-9123.
19. Cox J.L., Wilder P.J., Desler M., Rizzino A. Elevating SOX2 levels deleteriously affects the growth of medulloblastoma and glioblastoma cells. PLoS ONE 2012, 7:e44087.
20. Noh K.H., Kim B.W., Song K.H., Cho H., Lee Y.H., Kim J.H., Chung J.Y., Kim J.H., Hewitt S.M., Seong S.Y., Mao C.P., Wu T.C., Kim T.W. Nanog signaling in cancer promotes stem-like phenotype and immune evasion. J. Clin. Invest. 2012, 122:4077-4093.
21. Linn D.E., Yang X., Sun F., Xie Y., Chen H., Jiang R., Chen H., Chumsri S., Burger A.M., Qiu Y. A role for OCT4 in tumor initiation of drug-resistant prostate cancer cells. Genes Cancer 2010, 1:908-916.
22. Oishi N., Wang X.W. Novel therapeutic strategies for targeting liver cancer stem cells. Int. J. Biol. Sci. 2011, 7:517-535.
23. Kockar F., Yildrim H., Sagkan R.I., Hagemann C., Soysal Y., Anacker J., Hamza A.A., Vordermark D., Flentje M., Said H.M. Hypoxia and cytokines regulate carbonic anhydrase 9 expression in hepatocellular carcinoma cells in vitro. World J. Clin. Oncol. 2012, 3:82-91.
24. Chitcholtan K., Sykes P.H., Evans J.J. The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer. J. Transl. Med. 2012, 10:38.
25. Kim Y.J., Bae H.I., Kwon O.K., Choi M.S. Three-dimensional gastric cancer cell culture using nanofiber scaffold for chemosensitivity test. Int. J. Biol. Macromol. 2009, 45:65-71.
26. Karlsson H., Fryknäs M., Larsson R., Nygren P. Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system. Exp. Cell. Res. 2012, 318:1577-1585.
27. Nishihira T., Kasai M., Mori S., Watanabe T., Kuriya Y., Suda M., Kitamura M., Hirayama K., Akaishi T., Sasaki T. Characteristics of two cell lines (TE-1 and TE-2) derived from human squamous cell carcinoma of the esophagus. Gann 1979, 70:575-584.
28. Nishihira T., Hashimoto Y., Katayama M., Mori S., Kuroki T. Molecular and cellular features of esophageal cancer cells. J. Cancer Res. Clin. Oncol. 1993, 119:441-449.
29. Miyazaki T., Kato H., Nakajima M., Sohda M., Fukai Y., Masuda N., Manda R., Fukuchi M., Tsukada K., Kuwano H. FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br. J. Cancer 2003, 89:140-145.
30. Kwok S., Higuchi R. Avoiding false positives with PCR. Nature 1989, 339:237-238.
31. Sutherland R.M., McCredie J.A., Inch W.R. Growth of multicell sheriod in tissue culture as a model of nodular carcinomas. Natl. Cancer Inst. 1971, 46:113-120.
32. Holtfreter J. A study of the mechanics of gastrulation. J. Exp. Zool. 1944, 95:171-212.
33. Mueller-klieser W. Three-dimensional cell cultures: from molecular mechanisms to clinical applications. Am. J. Physiol. 1997, 273:C1109-C1123.
34. Watanabe M., Takagi A. The biological behavior of prostate cancer cells in 3D culture systems. Yakugaku Zasshi 2008, 128:37-44.
35. Skvortsova I., Skvortsov S., Raju U., Stasyk T., Riesterer O., Schottdorf E.M., Popper B.A., Schiestl B., Eichberger P., Debbage P., Neher A., Bonn G.K., Huber L.A., Milas L., Lukas P. Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse. Radiother. Oncol. 2010, 96:108-115.